Evidence map›Paper›PMID 36299881›Full record

ArticleFrontiers in pharmacology2022

Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey.

Jingjing Hou, Debbie Marriott, Dario Cattaneo, Sophie Stocker, Jana Stojanova, Jan-Willem Alffenaar, Chenlin Xiao, Yichang Zhao, Hui Gong, Miao Yan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Therapeutic drug monitoring in tuberculosis.European journal of clinical pharmacology · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Jingjing HouDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Debbie MarriottDepartment of Microbiology and Infectious Diseases, St. Vincent's Hospital, Sydney, NSW, Australia.
Dario CattaneoUnit of Clinical Pharmacology, ASST FBF Sacco University Hospital, Milan, Italy.
Sophie StockerSchool of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Jana StojanovaDepartment of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, NSW, Australia.
Jan-Willem AlffenaarSchool of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Chenlin XiaoDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Yichang ZhaoDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Hui GongDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Miao YanDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CNSt Vincent's Hospital Sydney · AUThe University of Sydney · AUASST Fatebenefratelli Sacco · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-infectiveclinical practiceinterpretationquestionnairetherapeutic drug monitoring

Identifiers

PMID36299881
PMCPMC9589087
OpenAlexW4304005569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.